Clinical Trial: Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: A Prospective Study of the Use of Micropulse 577nm Laser Treatment in Central Serous Chorioretinopathy

Brief Summary: The investigators hypothesis is that using the micropulse laser in patient with Central Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in significantly minimizing visual recovery time from this disease as well as potentially preventing recurrences.

Detailed Summary: The investigators hypothesize that application of 577nm micropulse laser in patients with CSC will prompt resolution of CSC as measured by ocular coherence tomography and best corrected visual acuity. This will be a pilot study to establish sound methods and provide some insights to the safety and efficacy of CSC treatment.
Sponsor: George Washington University

Current Primary Outcome: Resolution of fluid build-up [ Time Frame: within 1 week to 3 months after the laser procedure is completed ]

Central Serous Choroidopathy is a disease that causes fluid to build up under the retina,the back part of the inner eye that sends sight information to the brain. The objective here is to apply 577nm of micropulse laser to see if CSC resolution occurs and measuring it through ocular coherence tomography (retinal imaging), vision score, and visual field testing for retinal sensitivity.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: George Washington University

Dates:
Date Received: November 6, 2013
Date Started: November 2012
Date Completion: November 2016
Last Updated: November 12, 2013
Last Verified: October 2013